Apr 15, 2021
In the biopharmaceutical industry, there has been a shift away
from
on-site construction to prefabricated solutions. Peter
Makowenskyj,
Director of Sales Engineering at G-CON Manufacturing Inc.,
recently
told Pharmaceutical Technology that speed to market and lower
total cost of ownership for facilities has accelerated this
movement in the biopharma sector. He also discussed the strain that
the COVID-19 pandemic has placed on operations across the industry
and how the situation is creating a need for additional
capacity.